Search - tctmd.com

Displaying 181 - 200 of 233

Sort: Relevancy | Date

Presentation CDM 2017

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll

October 06, 2017

News Daily News

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Yael L. Maxwell

September 18, 2017

Manuscript

Cerebral Embolic Protection: Point–Counter Point

September 08, 2017

Manuscript

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

August 14, 2017

Podcast

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

August 10, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

News Industry News

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

July 11, 2017

News Daily News

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Caitlin E. Cox

June 21, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Conference News EuroPCR 2017

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Yael L. Maxwell

May 17, 2017

News Conference News ACC 2017

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

L.A. McKeown

March 21, 2017

Presentation ACC 2017

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Michael Mack

March 20, 2017

News Conference News ACC 2017

Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit

Todd Neale

March 19, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Shelley Wood

February 23, 2017

Presentation JIM 2017

Complete Cerebral Embolic Protection Utilizing TriGuard™

Presenter: Azeem Latib

February 10, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

Advertisement

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Cerebral Embolic Protection: Point–Counter Point

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit

Live From Washington: ACC 2017, Day Three

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Complete Cerebral Embolic Protection Utilizing TriGuard™

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content